跳至主要内容
临床试验/CTRI/2024/07/070540
CTRI/2024/07/070540尚未招募3 期

A prospective, comparative, randomized study on efficacy, safety of oral methotrexate vs oral tofacitinib in management of palmoplantar psoriasis. - Nil

KIRTI NITIN HAJARE0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Adult aged more than 18 years and less than 60 years
  • 2)Confirmed case of palmoplantar psoriasis by skin punch biopsy.
  • 3)History of palmoplantar psoriasis for atleast 6 months.
  • 4)Both male and female.

排除标准

  • 1)Age less than 18years and more than 60 years.
  • 2)Patient with nail psoriasis and psoriatic arthropathy.
  • 3)Patient unwilling to give consent.
  • 4)Patient with anemia and infections GI disease, respiratory diseases.
  • 5)Patient planning to have children.
  • 6)history of recent live vaccination
  • 7)Patient with co-morbidities.
  • 8)Alcohol consumption, tobacco and smoking.
  • 9)Organ transplant.
  • 10)Patient with thromboembolism, stroke, cardiovascular disease.

研究者

发起方
KIRTI NITIN HAJARE

相似试验